Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Transplantation | 99 | 2024 | 4285 | 7.950 |
Why?
|
Living Donors | 28 | 2022 | 651 | 2.810 |
Why?
|
Kidney Failure, Chronic | 25 | 2024 | 2489 | 2.280 |
Why?
|
Pancreas Transplantation | 11 | 2024 | 198 | 2.020 |
Why?
|
BK Virus | 6 | 2021 | 120 | 2.010 |
Why?
|
Graft Rejection | 31 | 2024 | 4505 | 1.730 |
Why?
|
Polyomavirus Infections | 5 | 2021 | 193 | 1.720 |
Why?
|
Tissue Donors | 17 | 2024 | 2377 | 1.510 |
Why?
|
Tumor Virus Infections | 4 | 2021 | 439 | 1.500 |
Why?
|
Donor Selection | 5 | 2022 | 240 | 1.370 |
Why?
|
Graft Survival | 20 | 2024 | 3890 | 1.170 |
Why?
|
Tissue and Organ Procurement | 15 | 2024 | 983 | 1.120 |
Why?
|
Immunosuppressive Agents | 18 | 2024 | 4213 | 1.010 |
Why?
|
Waiting Lists | 9 | 2023 | 778 | 0.940 |
Why?
|
Glomerular Filtration Rate | 12 | 2024 | 2226 | 0.800 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2023 | 291 | 0.670 |
Why?
|
Arteriovenous Fistula | 1 | 2023 | 321 | 0.670 |
Why?
|
Nephrectomy | 9 | 2020 | 949 | 0.650 |
Why?
|
Diabetes Mellitus, Type 1 | 7 | 2024 | 3440 | 0.640 |
Why?
|
Cytomegalovirus Infections | 5 | 2018 | 839 | 0.630 |
Why?
|
Kidney Function Tests | 5 | 2024 | 681 | 0.630 |
Why?
|
Complement Factor H | 1 | 2018 | 110 | 0.610 |
Why?
|
Glomerulonephritis | 2 | 2018 | 333 | 0.600 |
Why?
|
Diabetic Nephropathies | 3 | 2021 | 975 | 0.600 |
Why?
|
Glomerulonephritis, IGA | 1 | 2017 | 61 | 0.570 |
Why?
|
Sirolimus | 6 | 2010 | 1542 | 0.510 |
Why?
|
Kidney | 22 | 2024 | 7064 | 0.500 |
Why?
|
Renal Dialysis | 6 | 2023 | 1802 | 0.500 |
Why?
|
Creatinine | 7 | 2022 | 1915 | 0.490 |
Why?
|
Fibrinogen | 1 | 2018 | 892 | 0.490 |
Why?
|
Cytomegalovirus | 1 | 2018 | 755 | 0.460 |
Why?
|
Kidney Diseases | 4 | 2021 | 2102 | 0.450 |
Why?
|
Organ Transplantation | 6 | 2021 | 1177 | 0.450 |
Why?
|
Tissue and Organ Harvesting | 8 | 2019 | 374 | 0.440 |
Why?
|
Withholding Treatment | 1 | 2017 | 621 | 0.430 |
Why?
|
Antilymphocyte Serum | 4 | 2024 | 491 | 0.390 |
Why?
|
Islets of Langerhans Transplantation | 2 | 2007 | 748 | 0.390 |
Why?
|
Delayed Graft Function | 2 | 2024 | 53 | 0.380 |
Why?
|
Postoperative Complications | 13 | 2024 | 15880 | 0.370 |
Why?
|
Adrenal Cortex Hormones | 2 | 2017 | 1891 | 0.350 |
Why?
|
Vital Signs | 1 | 2011 | 144 | 0.340 |
Why?
|
Steroids | 3 | 2013 | 937 | 0.340 |
Why?
|
Proteinuria | 4 | 2023 | 613 | 0.330 |
Why?
|
Humans | 127 | 2024 | 768451 | 0.330 |
Why?
|
Mycophenolic Acid | 3 | 2010 | 350 | 0.320 |
Why?
|
Treatment Failure | 3 | 2010 | 2656 | 0.320 |
Why?
|
Fatigue | 2 | 2019 | 1556 | 0.310 |
Why?
|
Frail Elderly | 1 | 2014 | 774 | 0.310 |
Why?
|
Mandatory Testing | 1 | 2007 | 23 | 0.300 |
Why?
|
Polycystic Kidney Diseases | 1 | 2009 | 133 | 0.300 |
Why?
|
Critical Pathways | 1 | 2011 | 476 | 0.300 |
Why?
|
Liver Transplantation | 7 | 2022 | 2399 | 0.290 |
Why?
|
Long-Term Care | 1 | 2011 | 633 | 0.280 |
Why?
|
Cold Ischemia | 2 | 2024 | 73 | 0.270 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 1 | 2007 | 167 | 0.260 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2024 | 2291 | 0.250 |
Why?
|
Biopsy | 9 | 2024 | 6816 | 0.250 |
Why?
|
Protease Inhibitors | 1 | 2009 | 753 | 0.240 |
Why?
|
Patient Selection | 5 | 2012 | 4266 | 0.240 |
Why?
|
Boronic Acids | 1 | 2009 | 915 | 0.230 |
Why?
|
Quality of Life | 6 | 2023 | 13497 | 0.230 |
Why?
|
Registries | 2 | 2024 | 8373 | 0.230 |
Why?
|
Antiviral Agents | 5 | 2022 | 3063 | 0.220 |
Why?
|
Carcinoma, Renal Cell | 1 | 2019 | 3197 | 0.220 |
Why?
|
HLA-DQ Antigens | 2 | 2018 | 190 | 0.220 |
Why?
|
Prognosis | 12 | 2024 | 30028 | 0.220 |
Why?
|
Mood Disorders | 1 | 2010 | 1128 | 0.220 |
Why?
|
Pregnancy Complications | 1 | 2017 | 2969 | 0.220 |
Why?
|
Advisory Committees | 2 | 2019 | 797 | 0.210 |
Why?
|
Pyrazines | 1 | 2009 | 1206 | 0.210 |
Why?
|
Hypertension | 1 | 2023 | 8611 | 0.200 |
Why?
|
Diabetes Mellitus | 4 | 2012 | 5887 | 0.200 |
Why?
|
Cardiovascular Diseases | 4 | 2023 | 15638 | 0.200 |
Why?
|
Adult | 52 | 2024 | 223542 | 0.200 |
Why?
|
Viremia | 2 | 2022 | 725 | 0.200 |
Why?
|
Cysts | 1 | 2007 | 685 | 0.190 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 2 | 2001 | 897 | 0.190 |
Why?
|
House Calls | 2 | 2014 | 171 | 0.190 |
Why?
|
Hepatitis C, Chronic | 2 | 2022 | 1031 | 0.190 |
Why?
|
Renal Insufficiency | 3 | 2018 | 809 | 0.190 |
Why?
|
Transplantation, Homologous | 8 | 2021 | 4834 | 0.190 |
Why?
|
Middle Aged | 46 | 2024 | 223418 | 0.180 |
Why?
|
Prednisone | 2 | 2007 | 1568 | 0.180 |
Why?
|
Cystatin C | 1 | 2022 | 272 | 0.180 |
Why?
|
Survivors | 1 | 2011 | 2381 | 0.180 |
Why?
|
Kidney Glomerulus | 2 | 2018 | 569 | 0.170 |
Why?
|
Male | 50 | 2024 | 364781 | 0.170 |
Why?
|
Patient Readmission | 1 | 2014 | 3308 | 0.170 |
Why?
|
Nephrology | 1 | 2023 | 268 | 0.170 |
Why?
|
Follow-Up Studies | 14 | 2024 | 39430 | 0.160 |
Why?
|
Female | 51 | 2024 | 396943 | 0.160 |
Why?
|
Virus Activation | 2 | 2019 | 322 | 0.160 |
Why?
|
Recurrence | 3 | 2018 | 8510 | 0.160 |
Why?
|
T-Lymphocytes, Cytotoxic | 3 | 2002 | 1797 | 0.150 |
Why?
|
Complement Pathway, Alternative | 1 | 2018 | 113 | 0.150 |
Why?
|
Liver Diseases | 1 | 2007 | 1307 | 0.150 |
Why?
|
Pancreatic Diseases | 1 | 2020 | 353 | 0.150 |
Why?
|
Retrospective Studies | 19 | 2024 | 81834 | 0.150 |
Why?
|
Histocompatibility Testing | 2 | 2018 | 716 | 0.150 |
Why?
|
Risk Factors | 13 | 2024 | 74915 | 0.150 |
Why?
|
Time Factors | 14 | 2019 | 40271 | 0.150 |
Why?
|
Substance Abuse, Intravenous | 1 | 2022 | 530 | 0.140 |
Why?
|
Complement Activation | 1 | 2018 | 448 | 0.140 |
Why?
|
Lung Transplantation | 3 | 2001 | 1310 | 0.140 |
Why?
|
Palliative Care | 1 | 2012 | 3644 | 0.140 |
Why?
|
Primary Graft Dysfunction | 1 | 2017 | 112 | 0.130 |
Why?
|
Thrombotic Microangiopathies | 1 | 2017 | 124 | 0.130 |
Why?
|
Podocytes | 1 | 2020 | 402 | 0.130 |
Why?
|
Stress, Psychological | 2 | 2010 | 4538 | 0.130 |
Why?
|
Renal Replacement Therapy | 2 | 2024 | 283 | 0.120 |
Why?
|
Personal Satisfaction | 2 | 2018 | 648 | 0.120 |
Why?
|
Ribavirin | 1 | 2016 | 395 | 0.120 |
Why?
|
Aged | 29 | 2024 | 171520 | 0.120 |
Why?
|
United States | 18 | 2024 | 73121 | 0.110 |
Why?
|
Contraception | 1 | 2017 | 362 | 0.110 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2017 | 545 | 0.110 |
Why?
|
Mutation | 1 | 2018 | 30243 | 0.110 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 9507 | 0.110 |
Why?
|
RNA, Messenger | 6 | 2022 | 12813 | 0.110 |
Why?
|
Heart Transplantation | 2 | 2024 | 3291 | 0.110 |
Why?
|
Aftercare | 1 | 2019 | 921 | 0.110 |
Why?
|
Health Expenditures | 2 | 2016 | 2391 | 0.100 |
Why?
|
Costs and Cost Analysis | 2 | 2016 | 1670 | 0.100 |
Why?
|
Body Image | 1 | 2018 | 644 | 0.100 |
Why?
|
Sex Factors | 1 | 2006 | 10647 | 0.100 |
Why?
|
Oral Ulcer | 2 | 2010 | 96 | 0.100 |
Why?
|
Treatment Outcome | 17 | 2024 | 65409 | 0.100 |
Why?
|
Affect | 2 | 2018 | 1498 | 0.100 |
Why?
|
Hepatitis C | 1 | 2022 | 1594 | 0.100 |
Why?
|
Antibodies, Monoclonal | 1 | 2009 | 9263 | 0.100 |
Why?
|
Lost to Follow-Up | 1 | 2012 | 123 | 0.100 |
Why?
|
Unemployment | 1 | 2013 | 210 | 0.090 |
Why?
|
Interleukins | 1 | 1996 | 792 | 0.090 |
Why?
|
Reproduction | 2 | 2006 | 646 | 0.090 |
Why?
|
Cohort Studies | 5 | 2018 | 41797 | 0.090 |
Why?
|
Acute Disease | 6 | 2018 | 7246 | 0.090 |
Why?
|
Risk Assessment | 6 | 2017 | 24311 | 0.090 |
Why?
|
Pedigree | 1 | 2018 | 4545 | 0.090 |
Why?
|
Superinfection | 1 | 2010 | 63 | 0.090 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4120 | 0.090 |
Why?
|
Analysis of Variance | 2 | 2017 | 6242 | 0.090 |
Why?
|
Gene Expression | 4 | 1997 | 7605 | 0.080 |
Why?
|
Bronchoalveolar Lavage Fluid | 3 | 2001 | 762 | 0.080 |
Why?
|
Israel | 1 | 2011 | 726 | 0.080 |
Why?
|
Disease Transmission, Infectious | 1 | 2015 | 562 | 0.080 |
Why?
|
Social Adjustment | 1 | 2011 | 636 | 0.080 |
Why?
|
Fear | 1 | 2018 | 1494 | 0.080 |
Why?
|
Survival Rate | 4 | 2018 | 12875 | 0.080 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12096 | 0.080 |
Why?
|
Enterobacteriaceae Infections | 1 | 2010 | 190 | 0.080 |
Why?
|
Polymerase Chain Reaction | 5 | 2010 | 6091 | 0.080 |
Why?
|
Blood Pressure | 2 | 2023 | 8538 | 0.080 |
Why?
|
Plasmapheresis | 1 | 2009 | 207 | 0.080 |
Why?
|
Spouses | 1 | 2010 | 286 | 0.070 |
Why?
|
Immune Tolerance | 1 | 2017 | 2326 | 0.070 |
Why?
|
Immunity, Cellular | 2 | 2009 | 1561 | 0.070 |
Why?
|
Standard of Care | 1 | 2012 | 571 | 0.070 |
Why?
|
Peritoneal Dialysis | 1 | 2009 | 160 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2017 | 4419 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2017 | 4642 | 0.070 |
Why?
|
Reoperation | 2 | 2009 | 4342 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2021 | 12242 | 0.070 |
Why?
|
Death | 2 | 2009 | 683 | 0.070 |
Why?
|
Ventilator Weaning | 1 | 2008 | 170 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6537 | 0.070 |
Why?
|
Mother-Child Relations | 1 | 2011 | 501 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2022 | 4049 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2002 | 4586 | 0.070 |
Why?
|
Health Care Surveys | 3 | 2024 | 2437 | 0.070 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 1995 | 2568 | 0.070 |
Why?
|
Cardiac Tamponade | 1 | 2007 | 175 | 0.060 |
Why?
|
Lymphocyte Activation | 4 | 1998 | 5495 | 0.060 |
Why?
|
Liver Cirrhosis | 1 | 2016 | 1950 | 0.060 |
Why?
|
Area Under Curve | 1 | 2010 | 1640 | 0.060 |
Why?
|
Pancreas | 2 | 2024 | 1703 | 0.060 |
Why?
|
Prospective Studies | 9 | 2019 | 54914 | 0.060 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 695 | 0.060 |
Why?
|
Rupture | 1 | 2007 | 444 | 0.060 |
Why?
|
Intubation | 1 | 2005 | 140 | 0.060 |
Why?
|
Disclosure | 1 | 2011 | 750 | 0.060 |
Why?
|
Patient Education as Topic | 2 | 2013 | 2339 | 0.060 |
Why?
|
DNA | 1 | 2018 | 7213 | 0.060 |
Why?
|
Survival Analysis | 1 | 2017 | 10125 | 0.060 |
Why?
|
Candidiasis | 1 | 2007 | 367 | 0.060 |
Why?
|
Transplantation Immunology | 1 | 2006 | 538 | 0.060 |
Why?
|
Immunity, Humoral | 1 | 2009 | 613 | 0.060 |
Why?
|
Health Services Accessibility | 2 | 2013 | 5510 | 0.060 |
Why?
|
Granzymes | 3 | 2001 | 279 | 0.060 |
Why?
|
Chronic Disease | 1 | 2019 | 9382 | 0.060 |
Why?
|
Drug Administration Schedule | 2 | 2013 | 4861 | 0.060 |
Why?
|
Decision Making | 1 | 2018 | 3961 | 0.060 |
Why?
|
Polysomnography | 1 | 2010 | 1864 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2012 | 15460 | 0.050 |
Why?
|
Chemokine CCL5 | 3 | 2002 | 214 | 0.050 |
Why?
|
Databases, Factual | 2 | 2017 | 8081 | 0.050 |
Why?
|
Mass Screening | 1 | 2019 | 5455 | 0.050 |
Why?
|
HLA Antigens | 1 | 2009 | 1338 | 0.050 |
Why?
|
HIV Infections | 2 | 2024 | 17564 | 0.050 |
Why?
|
Pore Forming Cytotoxic Proteins | 2 | 2000 | 131 | 0.050 |
Why?
|
Lymphoproliferative Disorders | 1 | 2006 | 531 | 0.050 |
Why?
|
Interleukin-15 | 3 | 2002 | 185 | 0.050 |
Why?
|
Perforin | 2 | 2000 | 169 | 0.050 |
Why?
|
Recovery of Function | 2 | 2012 | 2994 | 0.050 |
Why?
|
Pericardium | 1 | 2007 | 679 | 0.050 |
Why?
|
Cadaver | 4 | 2012 | 1362 | 0.050 |
Why?
|
Fas Ligand Protein | 2 | 2000 | 218 | 0.050 |
Why?
|
Healthcare Disparities | 3 | 2014 | 3412 | 0.050 |
Why?
|
Fatal Outcome | 1 | 2007 | 1840 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4298 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 2 | 1996 | 808 | 0.050 |
Why?
|
Hypotension | 1 | 2008 | 888 | 0.050 |
Why?
|
ROC Curve | 1 | 2010 | 3624 | 0.050 |
Why?
|
Attitude to Health | 1 | 2010 | 2030 | 0.050 |
Why?
|
Transcription, Genetic | 5 | 2002 | 7599 | 0.050 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 2002 | 167 | 0.050 |
Why?
|
Anemia | 1 | 2011 | 1521 | 0.050 |
Why?
|
New England | 2 | 2020 | 1056 | 0.050 |
Why?
|
Renal Circulation | 1 | 2002 | 291 | 0.050 |
Why?
|
Informed Consent | 1 | 2007 | 1012 | 0.050 |
Why?
|
Transplantation Conditioning | 1 | 2007 | 1598 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8753 | 0.040 |
Why?
|
Serine Endopeptidases | 3 | 2001 | 1032 | 0.040 |
Why?
|
Adolescent | 12 | 2015 | 89168 | 0.040 |
Why?
|
Device Removal | 1 | 2005 | 641 | 0.040 |
Why?
|
Cytokines | 4 | 2001 | 7449 | 0.040 |
Why?
|
Urinary Bladder | 1 | 2006 | 1160 | 0.040 |
Why?
|
Practice Guidelines as Topic | 4 | 2019 | 7451 | 0.040 |
Why?
|
Autoantibodies | 1 | 2009 | 2131 | 0.040 |
Why?
|
Delphi Technique | 1 | 2024 | 879 | 0.040 |
Why?
|
Ganciclovir | 1 | 2000 | 256 | 0.040 |
Why?
|
Clinical Protocols | 2 | 2018 | 1444 | 0.040 |
Why?
|
Acyclovir | 1 | 2000 | 267 | 0.040 |
Why?
|
Comorbidity | 2 | 2020 | 10601 | 0.040 |
Why?
|
Immunologic Factors | 1 | 2009 | 1600 | 0.040 |
Why?
|
Body Weight | 1 | 2010 | 4630 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 622 | 0.040 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2020 | 492 | 0.040 |
Why?
|
Polyenes | 1 | 1998 | 68 | 0.040 |
Why?
|
Pregnancy | 3 | 2017 | 30179 | 0.040 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2002 | 336 | 0.040 |
Why?
|
Base Sequence | 4 | 2017 | 12428 | 0.040 |
Why?
|
Caregivers | 1 | 2010 | 2302 | 0.040 |
Why?
|
Antibodies, Viral | 2 | 2022 | 3212 | 0.040 |
Why?
|
Dialysis | 1 | 2017 | 73 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2014 | 26351 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 1 | 2012 | 3237 | 0.040 |
Why?
|
Laparoscopy | 2 | 2006 | 2056 | 0.040 |
Why?
|
Nitric Oxide Synthase | 1 | 2000 | 911 | 0.040 |
Why?
|
Reference Values | 2 | 2002 | 4941 | 0.040 |
Why?
|
T-Lymphocytes | 4 | 1998 | 10273 | 0.030 |
Why?
|
Attitude | 1 | 2022 | 773 | 0.030 |
Why?
|
Histocompatibility | 1 | 1998 | 322 | 0.030 |
Why?
|
Interleukin-2 | 3 | 2002 | 1894 | 0.030 |
Why?
|
HLA-DR Antigens | 1 | 2018 | 607 | 0.030 |
Why?
|
Ischemia | 1 | 2005 | 1900 | 0.030 |
Why?
|
Age Distribution | 2 | 2015 | 2881 | 0.030 |
Why?
|
Boston | 3 | 2015 | 9361 | 0.030 |
Why?
|
Age Factors | 4 | 2024 | 18478 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1760 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2014 | 10358 | 0.030 |
Why?
|
Health Surveys | 2 | 2020 | 4056 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 1409 | 0.030 |
Why?
|
Hepacivirus | 1 | 2022 | 1342 | 0.030 |
Why?
|
Drug Resistance | 1 | 2001 | 1599 | 0.030 |
Why?
|
Anti-Retroviral Agents | 1 | 2024 | 1794 | 0.030 |
Why?
|
Substance-Related Disorders | 1 | 2011 | 4453 | 0.030 |
Why?
|
Coronary Artery Disease | 2 | 2019 | 6551 | 0.030 |
Why?
|
Consensus | 1 | 2024 | 3207 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2002 | 2003 | 0.030 |
Why?
|
Decision Support Techniques | 2 | 2015 | 2010 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2014 | 509 | 0.030 |
Why?
|
Blotting, Western | 1 | 2001 | 5042 | 0.030 |
Why?
|
DNA Primers | 1 | 2017 | 2826 | 0.030 |
Why?
|
Hospitals, University | 2 | 2009 | 569 | 0.030 |
Why?
|
Heart Diseases | 1 | 2005 | 2816 | 0.030 |
Why?
|
Chemokines | 1 | 1997 | 963 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1996 | 1355 | 0.030 |
Why?
|
In Situ Hybridization | 1 | 1996 | 1906 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2017 | 1869 | 0.020 |
Why?
|
Membrane Glycoproteins | 2 | 2000 | 3713 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2005 | 3805 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2022 | 2008 | 0.020 |
Why?
|
DNA, Complementary | 1 | 1995 | 1992 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2012 | 417 | 0.020 |
Why?
|
Immunoconjugates | 1 | 1998 | 968 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2002 | 11138 | 0.020 |
Why?
|
Drug Therapy, Combination | 2 | 2016 | 6320 | 0.020 |
Why?
|
DNA, Viral | 1 | 2017 | 2206 | 0.020 |
Why?
|
Antigen Presentation | 1 | 1996 | 1251 | 0.020 |
Why?
|
Role | 1 | 2010 | 176 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2001 | 5904 | 0.020 |
Why?
|
Cell Line | 3 | 2001 | 15609 | 0.020 |
Why?
|
Young Adult | 5 | 2015 | 60045 | 0.020 |
Why?
|
Interleukin-7 | 2 | 2002 | 144 | 0.020 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1763 | 0.020 |
Why?
|
Glucose | 1 | 2021 | 4355 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2019 | 2239 | 0.020 |
Why?
|
Regression Analysis | 2 | 2014 | 6353 | 0.020 |
Why?
|
Cultural Competency | 1 | 2012 | 303 | 0.020 |
Why?
|
Molecular Sequence Data | 3 | 1997 | 17647 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2021 | 3111 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4572 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2012 | 20762 | 0.020 |
Why?
|
Actuarial Analysis | 2 | 1998 | 372 | 0.020 |
Why?
|
Child | 8 | 2009 | 80863 | 0.020 |
Why?
|
Rabbits | 1 | 2013 | 4786 | 0.020 |
Why?
|
Incidence | 2 | 2020 | 21552 | 0.020 |
Why?
|
Genetic Testing | 1 | 2020 | 3586 | 0.020 |
Why?
|
Proteins | 1 | 2002 | 6008 | 0.020 |
Why?
|
Calcium | 1 | 2020 | 5793 | 0.020 |
Why?
|
Family | 2 | 2008 | 3208 | 0.020 |
Why?
|
Cyclosporine | 1 | 2009 | 780 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 22386 | 0.020 |
Why?
|
Albuminuria | 1 | 2009 | 658 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2020 | 26395 | 0.020 |
Why?
|
Tacrolimus | 1 | 2009 | 750 | 0.020 |
Why?
|
Patient Participation | 1 | 2014 | 1450 | 0.020 |
Why?
|
Lymphocyte Cooperation | 1 | 1984 | 112 | 0.010 |
Why?
|
Health Personnel | 1 | 2018 | 3384 | 0.010 |
Why?
|
Glucose Tolerance Test | 1 | 2007 | 1181 | 0.010 |
Why?
|
Mitochondria | 1 | 2017 | 3672 | 0.010 |
Why?
|
Intraoperative Period | 1 | 2005 | 513 | 0.010 |
Why?
|
Animals | 4 | 2013 | 169418 | 0.010 |
Why?
|
Algorithms | 2 | 2015 | 14158 | 0.010 |
Why?
|
Reperfusion | 1 | 2005 | 271 | 0.010 |
Why?
|
Socioeconomic Factors | 2 | 2008 | 7863 | 0.010 |
Why?
|
Medical History Taking | 1 | 2007 | 776 | 0.010 |
Why?
|
Contraceptives, Oral | 1 | 2006 | 562 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15880 | 0.010 |
Why?
|
Patient-Centered Care | 1 | 2013 | 1439 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 1996 | 4781 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2014 | 3484 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2012 | 2731 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 1998 | 11930 | 0.010 |
Why?
|
Macrophages | 1 | 1996 | 5797 | 0.010 |
Why?
|
Risk | 1 | 2013 | 9642 | 0.010 |
Why?
|
Cost of Illness | 1 | 2010 | 1960 | 0.010 |
Why?
|
Receptors, Interleukin | 1 | 2002 | 242 | 0.010 |
Why?
|
Social Support | 1 | 2010 | 2195 | 0.010 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2002 | 307 | 0.010 |
Why?
|
bcl-X Protein | 1 | 2002 | 412 | 0.010 |
Why?
|
Intubation, Intratracheal | 1 | 2008 | 1359 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 22293 | 0.010 |
Why?
|
Health Status Disparities | 1 | 2011 | 1876 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2010 | 2665 | 0.010 |
Why?
|
Heme Oxygenase-1 | 1 | 2002 | 366 | 0.010 |
Why?
|
Logistic Models | 1 | 2014 | 13324 | 0.010 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2000 | 518 | 0.010 |
Why?
|
Interleukin-8 | 1 | 2002 | 705 | 0.010 |
Why?
|
Prenatal Care | 1 | 2006 | 1159 | 0.010 |
Why?
|
Psychometrics | 1 | 2008 | 3072 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 2000 | 1379 | 0.010 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2002 | 635 | 0.010 |
Why?
|
Nephrotic Syndrome | 1 | 2002 | 382 | 0.010 |
Why?
|
Interleukin-4 | 1 | 2002 | 1158 | 0.010 |
Why?
|
Child, Preschool | 3 | 2009 | 42623 | 0.010 |
Why?
|
Patient Care Team | 1 | 2007 | 2526 | 0.010 |
Why?
|
Research Design | 1 | 2012 | 6217 | 0.010 |
Why?
|
Interleukin-17 | 1 | 2002 | 923 | 0.010 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 1996 | 510 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 1998 | 920 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6657 | 0.010 |
Why?
|
Blood Glucose | 1 | 2009 | 6429 | 0.010 |
Why?
|
Immunoglobulin Variable Region | 1 | 1996 | 420 | 0.010 |
Why?
|
Organ Preservation | 1 | 1997 | 389 | 0.010 |
Why?
|
Cold Temperature | 1 | 1997 | 786 | 0.010 |
Why?
|
California | 1 | 1997 | 1444 | 0.010 |
Why?
|
Administration, Oral | 1 | 2000 | 4041 | 0.010 |
Why?
|
Infant | 2 | 2009 | 36497 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2002 | 2882 | 0.010 |
Why?
|
Physicians | 1 | 2009 | 4615 | 0.010 |
Why?
|
Surgical Wound Infection | 1 | 2000 | 1544 | 0.010 |
Why?
|
Dexamethasone | 1 | 1998 | 1965 | 0.010 |
Why?
|
Kinetics | 1 | 1998 | 6348 | 0.010 |
Why?
|
RNA | 1 | 2000 | 2727 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 1996 | 1751 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2008 | 20231 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 1996 | 1362 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1998 | 6527 | 0.000 |
Why?
|
Antigens, CD | 1 | 1998 | 4029 | 0.000 |
Why?
|
Nuclear Proteins | 1 | 2002 | 5808 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2012 | 59680 | 0.000 |
Why?
|
Obesity | 1 | 2007 | 13065 | 0.000 |
Why?
|
Membrane Proteins | 1 | 2002 | 7895 | 0.000 |
Why?
|
Hemolytic Plaque Technique | 1 | 1984 | 59 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2002 | 9623 | 0.000 |
Why?
|
Antibody-Producing Cells | 1 | 1984 | 140 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1998 | 19041 | 0.000 |
Why?
|
Sheep | 1 | 1984 | 1451 | 0.000 |
Why?
|
Clone Cells | 1 | 1984 | 1672 | 0.000 |
Why?
|
Antigens, Surface | 1 | 1984 | 1615 | 0.000 |
Why?
|
Spleen | 1 | 1984 | 2298 | 0.000 |
Why?
|
Cell Adhesion | 1 | 1984 | 3103 | 0.000 |
Why?
|
Mice, Inbred BALB C | 1 | 1984 | 6241 | 0.000 |
Why?
|
Phenotype | 1 | 1984 | 16712 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 1984 | 22365 | 0.000 |
Why?
|
Mice | 1 | 1984 | 82045 | 0.000 |
Why?
|